Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye Diseases | 2 | 2021 | 94 | 1.240 |
Why?
|
| Retinopathy of Prematurity | 3 | 2026 | 179 | 0.910 |
Why?
|
| Esotropia | 1 | 2023 | 27 | 0.750 |
Why?
|
| Botulinum Toxins | 1 | 2023 | 46 | 0.730 |
Why?
|
| Pontine Tegmentum | 1 | 2020 | 4 | 0.670 |
Why?
|
| Cerebellar Diseases | 1 | 2020 | 27 | 0.650 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 43 | 0.650 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 47 | 0.630 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 281 | 0.530 |
Why?
|
| Keratoconus | 2 | 2025 | 23 | 0.440 |
Why?
|
| Anesthesia, General | 2 | 2025 | 118 | 0.410 |
Why?
|
| Corneal Topography | 2 | 2025 | 25 | 0.280 |
Why?
|
| Visual Acuity | 2 | 2026 | 489 | 0.240 |
Why?
|
| Laser Coagulation | 1 | 2026 | 77 | 0.230 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 2025 | 22 | 0.220 |
Why?
|
| Riboflavin | 1 | 2025 | 15 | 0.220 |
Why?
|
| Corneal Stroma | 1 | 2025 | 24 | 0.220 |
Why?
|
| Photochemotherapy | 1 | 2025 | 39 | 0.220 |
Why?
|
| Tomography | 1 | 2025 | 45 | 0.220 |
Why?
|
| Photosensitizing Agents | 1 | 2025 | 42 | 0.220 |
Why?
|
| Patient Positioning | 1 | 2025 | 70 | 0.210 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2026 | 237 | 0.210 |
Why?
|
| Cytomegalovirus | 1 | 2025 | 168 | 0.210 |
Why?
|
| Cross-Linking Reagents | 1 | 2025 | 207 | 0.210 |
Why?
|
| Gestational Age | 3 | 2026 | 975 | 0.210 |
Why?
|
| Cornea | 1 | 2025 | 155 | 0.200 |
Why?
|
| Infant, Newborn | 4 | 2026 | 6429 | 0.190 |
Why?
|
| Infant | 5 | 2026 | 10034 | 0.190 |
Why?
|
| Exotropia | 1 | 2023 | 25 | 0.190 |
Why?
|
| Collagen | 1 | 2025 | 456 | 0.180 |
Why?
|
| Strabismus | 1 | 2023 | 71 | 0.180 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2023 | 90 | 0.180 |
Why?
|
| Child, Preschool | 5 | 2025 | 11787 | 0.180 |
Why?
|
| Birth Weight | 2 | 2022 | 522 | 0.170 |
Why?
|
| Physical Examination | 1 | 2021 | 239 | 0.150 |
Why?
|
| Mucolipidoses | 1 | 2019 | 9 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2025 | 675 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2025 | 534 | 0.140 |
Why?
|
| Mass Screening | 1 | 2025 | 1347 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 544 | 0.120 |
Why?
|
| Humans | 13 | 2026 | 144759 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2026 | 11679 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2026 | 17066 | 0.110 |
Why?
|
| Cognition | 1 | 2021 | 1266 | 0.090 |
Why?
|
| Risk Factors | 3 | 2022 | 10779 | 0.090 |
Why?
|
| Colorado | 2 | 2020 | 4564 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2014 | 326 | 0.090 |
Why?
|
| Education, Medical | 1 | 2014 | 274 | 0.080 |
Why?
|
| Adolescent | 4 | 2025 | 22428 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2013 | 233 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2020 | 5960 | 0.080 |
Why?
|
| Smoking Cessation | 1 | 2013 | 439 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2026 | 5408 | 0.070 |
Why?
|
| Child | 6 | 2025 | 22633 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 780 | 0.070 |
Why?
|
| Male | 7 | 2026 | 72315 | 0.070 |
Why?
|
| Incidence | 2 | 2025 | 2879 | 0.060 |
Why?
|
| Intravitreal Injections | 1 | 2026 | 71 | 0.060 |
Why?
|
| Female | 6 | 2026 | 78271 | 0.060 |
Why?
|
| Bevacizumab | 1 | 2026 | 167 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2013 | 1289 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2026 | 557 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2025 | 388 | 0.050 |
Why?
|
| Neonatal Screening | 1 | 2022 | 178 | 0.040 |
Why?
|
| Eye Movement Measurements | 1 | 2019 | 14 | 0.040 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2019 | 53 | 0.040 |
Why?
|
| Educational Status | 1 | 2021 | 467 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2834 | 0.030 |
Why?
|
| Young Adult | 2 | 2025 | 14105 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2022 | 611 | 0.030 |
Why?
|
| Adult | 4 | 2025 | 40449 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2019 | 271 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4282 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2847 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2013 | 119 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2013 | 80 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 144 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 197 | 0.020 |
Why?
|
| Physician Assistants | 1 | 2013 | 102 | 0.020 |
Why?
|
| Documentation | 1 | 2013 | 198 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3671 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 465 | 0.020 |
Why?
|
| Students, Medical | 1 | 2014 | 375 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 948 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2013 | 851 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2013 | 1173 | 0.010 |
Why?
|